Schneider, C, Oellerich, T, Baldauf, H-M, Schwarz, S-M, Thomas, D, Flick, R, Bohnenberger, H, Kaderali, L, Stegmann, L, Cremer, A, Martin, M, Lohmeyer, J, Michaelis, M, Hornung, V, Schliemann, C, Berdel, WE, Hartmann, W, Wardelmann, E, Comoglio, F, Hansmann, M-L
, Yakunin, AF, Geisslinger, G, Stroebel, P, Ferreiros, N, Serve, H, Keppler, OT & Cinatl, JJ 2017, '
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia',
Nature Medicine, cyfrol. 23, rhif 2, tt. 250-255.
https://doi.org/10.1038/nm.4255